German AMLCG-Survivorship Study: Anxiety and Depression Symptoms in AML Long-Term Survivors

Grunddaten zum Vortrag

Art des Vortragswissenschaftlicher Vortrag
Name der VortragendenGörlich, Dennis
Datum des Vortrags11.12.2022
VortragsspracheEnglisch
DOI10.1182/blood-2022-156647

Informationen zur Veranstaltung

Name der Veranstaltung64th Annual Meeting of the American Society of Hematology
Zeitraum der Veranstaltung10.12.2022 - 13.12.2022
Ort der VeranstaltungNew Orleans, USA
Webseite der Veranstaltunghttps://www.hematology.org/meetings/annual-meeting
Veranstaltet von American Society of Hematology

Zusammenfassung

Abstract Background and Methods In the German AMLCG Survivorship study, we included former AML patients from the AMLCG 1999, 2004, 2008 trials and the AMLCG patient registry, who survived at least 5 years after their initial diagnosis (AML-LTS). Our participants provided information on life satisfaction, quality of life as well as a number of psychological outcomes. Here, we analyzed the hospital anxiety and depression scale questionnaire and present results with respect to severity of observed anxiety (HADS-A) and depression scores (HADS-D), as well as an exploratory analysis to identify major risk factors. We analyzed our data using absolute and relative frequencies. Categorical variables were compared by chi-squared tests. Univariate and multivariable logistic regression models were fitted to analyze the risk of increased anxiety or depression scores. Results 427 AML-LTS participated in this study 5 to 18.6 years after their initial AML diagnosis. Overall, long term survivors showed HADS depression values between 0 and 19 with higher values indicating more severe depression. On average, former patients scored 4.35 (SD=3.8) points. Based on the classification proposed by Zigmond et al., 77.5% (331/420) showed normal depression scores (range: 0-7), 12.9% (55/420) borderline depression scores (8-10) and 8% (34/420) high scores (>10). Anxiety scores ranged between 0 and 20. Average score was 5.55 (SD: 4.01). Anxiety seem to be a more prominent problem in former AML patients. 73.3% (313/418) showed a normal score, 13.3% (57/418) a borderline score and 11.2% (48/418) a high score. While depression severity was equally distributed between sexes (P >.05), anxiety is more prominent in women (male cases 10/182, 5.5% vs. female cases 38/236, 16.1%, P = .003). Older participants show a decreased risk for high (>10) anxiety scores (odds ratio per 10 years of age (OR): .776, 95% confidence interval (CI): .618-.970), but not for depression (P >.05). Time since initial diagnosis did not associate with depression or anxiety (P > .05). The equivalence income (household income in EUR, dependent on household size) was associated with depression risk (OR: .54, 95%CI: .34-.88, per 1000 EUR), but not with anxiety (P > .05). Changes in the occupational situation (due to AML) impacts the chance for high depression (P = .001) and high anxiety scores (P
StichwörterAML, Anxiety, Depression, Cancer Survivvorship

Vortragende der Universität Münster

Görlich, Dennis
Institut für Biometrie und Klinische Forschung (IBKF)